Your session is about to expire
← Back to Search
MIBG Therapy for Cancer (MIBG Trial)
MIBG Trial Summary
This trial is to study the effects of the radiopharmaceutical <131>I-MIBG on patients with tumors that concentrate the agent. The study will also evaluate the side effects of the therapy.
MIBG Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMIBG Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MIBG Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Can elderly individuals aged 75 or more participate in this investigation?
"This study is recruiting participants aged between 12 months and 65 years."
Is there any way I can partake in this trial?
"To gain entry into this research trial, prospective participants must have tumors and be between twelve months and sixty-five years of age. Approximately 65 candidates are being sought out for the study."
Has the FDA sanctioned MIBG for clinical use?
"Due to the lack of efficacy data, MIBG was rated a 2 on our safety scale. This is attributable to its Phase 2 trial status which suggests some evidence for safety but no proof of efficiency."
What is the principal application of MIBG?
"Paraganglioma can be addressed with the use of MIBG. Additionally, this radionuclide therapy is effective at treating neoplasms metastasis, primary neuroblastomas, and inoperable metastatic iobenguane-scan positive pheochromocytomas."
Is there still an opportunity for participants to join this scientific experiment?
"This clinical trial has since concluded, with the initial posting of March 1st 2014 and its last update on September 12th 2023. Other trials presently recruiting patients who have tumors are available as well as 5 studies involving MIBG treatments."
How many people are involved in this trial at present?
"At present, this clinical trial is not recruiting new patients. The study was initially posted on March 1st 2014 and the latest update was made on September 12th 2023. If you are seeking alternative trials, there are currently one actively enrolling participants with tumors and five other MIBG studies that need volunteers."
Share this study with friends
Copy Link
Messenger